QR код

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

Abstract Migraine headache is a common, chronic, debilitating disease with a complex etiology. Current therapy for migraine headache comprises either treatments targeting acute migraine pain or prophylactic therapy aimed at increasing the length of time between migraine episodes. Recent evidence sug...

Повний опис

Збережено в:
Автори: Ivan Urits, Gavin Clark, Daniel An, Bredan Wesp, Rebecca Zhou, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Anh L. Ngo, Alan D. Kaye, Rachel J. Kaye, Elyse M. Cornett, Omar Viswanath
Формат: Artigo
Мова:Inglês
Опубліковано: Adis, Springer Healthcare 2020-03-01
Серія:Pain and Therapy
Предмети:
Chronic pain
CGRP
Fremanezumab
Headache
Migraine
Monoclonal antibody
Онлайн доступ:https://doi.org/10.1007/s40122-020-00159-3
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси